Clinical Trial Update: TArgeting Type 1 Diabetes Using POLyamines (TADPOL) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (TADPOL) evaluating polyamines for Type 1 Diabetes is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• POLyamines

Snippet

Sponsor: Emily K. Sims | Conditions: Type 1 Diabetes | Phase 2 | Status: RECRUITING